Cancer cells can inhibit the functions of T lymphocytes, such as that of CD8 and CD4, which play a crucial role in recognizing and eliminating cancer cells, thereby creating a challenge in anti-tumor immune responses (Schreiber et al., 2011). This evidence concerns the gene CD4 and cancer.